Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Nov. 16, 2021
Dec. 31, 2022
Mar. 31, 2023
Subsidiary, Sale of Stock [Line Items]      
Waived deferred underwriting fee   $ 342,975  
Retained Earnings [Member]      
Subsidiary, Sale of Stock [Line Items]      
Waived deferred underwriting fee   $ 6,655,361  
Underwriting Agreement [Member]      
Subsidiary, Sale of Stock [Line Items]      
Underwriter cash discount per unit $ 0.20    
Payment of underwriting commissions $ 3,999,049    
Deferred fee $ 0.35    
Deferred underwriting fee $ 6,998,336    
Over-Allotment Option [Member]      
Subsidiary, Sale of Stock [Line Items]      
Purchase of additional shares 2,495,246   2,625,000
Offering price per share $ 10.00    
Proceeds from shares $ 24,952,460